Papaverine Prostaglandin recalls
The FDA has published 2 recalls involving Papaverine Prostaglandin since 2016. The latest was reported on 24 Feb 2016. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Feb 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why papaverine prostaglandin is recalled
Companies
By year
All papaverine prostaglandin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | papaverine prostaglandin 30 mg/30 mcg/mL unit size recalled | Abbott's Compounding Pharmacy | Sterility | CA |
| Drug | CLASS II | papaverine prostaglandin 30 mg/20 mcg/mL unit size recalled | Abbott's Compounding Pharmacy | Sterility | CA |
Should you stop taking Papaverine Prostaglandin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.